Abstract
Plasma BNP, a noble biomarker, increases proportionately with increasing left ventricular pressure. It is well documented that plasma BNP increases in left ventricular systolic dysfunction. Our study is to evaluate the role of plasma BNP level in early diagnosis of left ventricular diastolic dysfunction in patients with risk factors like hypertension, diabetes, dyslipidemia, ischemic heart disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
